Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
VP301 / Virtuoso Therap
NCT05698888: Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors	Terminated	1	2	US	VP301	Virtuoso BINco, Inc.	Solid Tumors, Adult, Multiple Myeloma, Lymphoma	06/23	06/23
VBI-002 / Virtuoso Therap
No trials found
VBI-003 / Virtuoso Therap
No trials found
Undisclosed CD47 x guide arm 3 bispecific antibody / Virtuoso Therap
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
VP301 / Virtuoso Therap
NCT05698888: Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors	Terminated	1	2	US	VP301	Virtuoso BINco, Inc.	Solid Tumors, Adult, Multiple Myeloma, Lymphoma	06/23	06/23
VBI-002 / Virtuoso Therap
No trials found
VBI-003 / Virtuoso Therap
No trials found
Undisclosed CD47 x guide arm 3 bispecific antibody / Virtuoso Therap
No trials found